{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:37:08Z","timestamp":1773365828872,"version":"3.50.1"},"reference-count":45,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Sp. 2","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>Introduction. Inborn errors of immunity is a diverse group of rare diseases caused by over 400 genetic mutations affecting the immune system and increasing infection susceptibility, autoimmunity, and malignancy. Hematopoietic stem cell transplantation offers a curative option for some inborn errors of immunity, with haploidentical donors providing a viable alternative when identical donors are unavailable.Objective. To determine survival, usefulness of weekly chimerism monitoring, immune reconstitution, and complications in patients with inborn errors of immunity who underwent haploidentical hematopoietic stem cell transplantation at a reference center in Colombia.Materials and methods. We conducted a retrospective and observational study of a case series of pediatric patients who underwent haploidentical hematopoietic stemcell transplantation with post-transplant cyclophosphamide and follow-up with weekly chimerism. Survival analysis was performed using the Kaplan-Meier method.Results. Sixteen patients with haploidentical familial donor transplantation were included. The most frequent diagnosis was severe combined immunodeficiency (n=5). Eleven out of seventeen patients received a non-myeloablative conditioning regimen. Twelve out of sixteen patients developed acute graft-versus-host disease. Out of these, 3 corresponded to grades III-IV. Post-transplant infections affected 14 of the subjects, predominating bacterial agents. Median T-cell chimerism was greater than 80% during the follow-up. Reconstitution of B and T lymphocytes was achieved in more than 80%. Overall survival at five years was 81%. Survival at 100 days was 94%.Conclusion. Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide is a viable alternative for inborn errors of immunity when an identical donor is unavailable. Serial chimerism monitoring is useful for graft follow-up.<\/jats:p>","DOI":"10.7705\/biomedica.7560","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:50:52Z","timestamp":1736437852000},"page":"118-130","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia","Trasplante haploid\u00e9ntico de c\u00e9lulas progenitoras hematopoy\u00e9ticas con ciclofosfamida despu\u00e9s del trasplante en errores innatos de la inmunidad: experiencia en un centro de referencia en Colombia"],"prefix":"10.7705","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1465-7957","authenticated-orcid":false,"given":"Diego","family":"Medina","sequence":"first","affiliation":[{"name":"Unidad de Trasplante de Progenitores Hematopoy\u00e9ticos, Servicio de Hemato-Oncolog\u00eda Pedi\u00e1trica, Departamento Materno Infantil, Fundaci\u00f3n Valle del Lili, Cali, Colombia;\u00a0Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"},{"name":"Unidad de Trasplante de Progenitores Hematopoy\u00e9ticos, Servicio de Hemato-Oncolog\u00eda Pedi\u00e1trica, Departamento Materno Infantil, Fundaci\u00f3n Valle del Lili, Cali, Colombia;\u00a0Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-5985","authenticated-orcid":false,"given":"Jhonier Orlando","family":"Castro","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"},{"name":"Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-3698","authenticated-orcid":false,"given":"David Esteban","family":"Castro","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"},{"name":"Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-8356","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Beltr\u00e1n","sequence":"additional","affiliation":[{"name":"Centro de Investigaciones Cl\u00ednicas, Fundaci\u00f3n Valle del Lili, Cali, Colombia"},{"name":"Centro de Investigaciones Cl\u00ednicas, Fundaci\u00f3n Valle del Lili, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5577-970X","authenticated-orcid":false,"given":"Eliana","family":"Manzi","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia;\u00a0Centro de Investigaciones Cl\u00ednicas, Fundaci\u00f3n Valle del Lili, Cali, Colombia"},{"name":"Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia;\u00a0Centro de Investigaciones Cl\u00ednicas, Fundaci\u00f3n Valle del Lili, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3173-6059","authenticated-orcid":false,"given":"Alexis Antonio","family":"Franco","sequence":"additional","affiliation":[{"name":"Unidad de Trasplante de Progenitores Hematopoy\u00e9ticos, Servicio de Hemato-Oncolog\u00eda Pedi\u00e1trica, Departamento Materno Infantil, Fundaci\u00f3n Valle del Lili, Cali, Colombia;\u00a0Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"},{"name":"Unidad de Trasplante de Progenitores Hematopoy\u00e9ticos, Servicio de Hemato-Oncolog\u00eda Pedi\u00e1trica, Departamento Materno Infantil, Fundaci\u00f3n Valle del Lili, Cali, Colombia;\u00a0Facultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-8928","authenticated-orcid":false,"given":"Manuela","family":"Olaya","sequence":"additional","affiliation":[{"name":"acultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia; Servicio de Alergolog\u00eda e Inmunolog\u00eda Pedi\u00e1trica, Departamento Materno-Infantil, Fundaci\u00f3n Valle del Lili, Cali, Colombia"},{"name":"acultad de Ciencias de la Salud, Universidad ICESI, Cali, Colombia; Servicio de Alergolog\u00eda e Inmunolog\u00eda Pedi\u00e1trica, Departamento Materno-Infantil, Fundaci\u00f3n Valle del Lili, Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"141952","doi-asserted-by":"crossref","unstructured":"Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40:24-64. https:\/\/doi.org\/10.1007\/s10875-019-00737-x","DOI":"10.1007\/s10875-019-00737-x"},{"key":"141953","doi-asserted-by":"crossref","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 Update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508-20.","DOI":"10.1007\/s10875-022-01352-z"},{"key":"141954","doi-asserted-by":"crossref","unstructured":"Leiva LE, Bezrodnik L, Oleastro M, Condino-Neto A, Costa-Carvalho BT, Sevciovic Grumach A, et al. Primary immunodeficiency diseases in Latin America: Proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board. Allergol Immunopathol (Madr). 2011;39:106-10. https:\/\/doi.org\/10.1007\/s10875-019-00737-x","DOI":"10.1016\/j.aller.2010.10.007"},{"key":"141955","unstructured":"V\u00e1squez E, Villada F, Orrego J, Franco J. Espectro de las inmunodeficiencias primarias en Colombia: reporte del Centro Nacional de Referencia Jeffrey Modell para diagno\u0301stico e investigacio\u0301n en inmunodeficiencias primarias (CJM-UDEA). Iatreia. 2013;26(Suppl.3):S43. https:\/\/doi.org\/10.17533\/udea.iatreia.15760"},{"key":"141956","doi-asserted-by":"crossref","unstructured":"Mccurdy SR, Luznik L. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide. Blood. 2019;134:1802-10. https:\/\/doi.org\/10.1182\/blood.2019001323","DOI":"10.1182\/blood.2019001323"},{"key":"141957","doi-asserted-by":"crossref","unstructured":"Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: One size does not fit all. Blood. 2014;124:344-53. https:\/\/doi.org\/10.1182\/blood-2014-02-514778","DOI":"10.1182\/blood-2014-02-514778"},{"key":"141958","doi-asserted-by":"crossref","unstructured":"Yanagimachi M, Kato K, Iguchi A, Sasaki K, Kiyotani C, Koh K, et al. Hematopoietic cell transplantation for chronic granulomatous disease in Japan. Front Immunol. 2020;11:1617. https:\/\/doi.org\/10.3389\/fimmu.2020.01617","DOI":"10.3389\/fimmu.2020.01617"},{"key":"141959","doi-asserted-by":"crossref","unstructured":"Laberko A, Gennery AR. Clinical considerations in the hematopoietic stem cell transplant management of primary immunodeficiencies. Expert Rev Clin Immunol. 2018;14:297-306. https:\/\/doi.org\/10.1080\/1744666X.2018.1459189","DOI":"10.1080\/1744666X.2018.1459189"},{"key":"141960","unstructured":"P\u00e9rez G, Olaya V, Del Campo M, Gayt\u00e1n M, M\u00fajica G, Ju\u00e1rez N, et al. Reconstituci\u00f3n inmunol\u00f3gica en ni\u00f1os receptores de trasplante de c\u00e9lulas progenitoras hematopoy\u00e9ticas. Alerg Asma Inmunol Pediatr. 2012;21:72-9."},{"key":"141961","doi-asserted-by":"crossref","unstructured":"Rif\u00f3n JJ. Trasplante de progenitores hemopoy\u00e9ticos. An Sist Sanit Navar. 2006:29(Suppl.2):137-51.","DOI":"10.4321\/S1137-66272006000400013"},{"key":"141962","unstructured":"Cruz CH, Carnot Uria J, Perurena JM, Llauger KC, Pardo I, Hospital R, et al. El trasplante alog\u00e9nico haploid\u00e9ntico: un traje hecho a la medida de nuestras condiciones y necesidades. Rev Cubana Med. 2017;56."},{"key":"141963","doi-asserted-by":"crossref","unstructured":"Trujillo \u00c1M, Karduss AJ, Su\u00e1rez G, P\u00e9rez R, Ruiz G, Cardona A, et al. Haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide in children with high-risk leukemia using a reduced-intensity conditioning regimen and peripheral blood as the stem cell source. Transplant Cell Ther. 2021;27:427.e1-427.e7. https:\/\/doi.org\/10.1016\/j.jtct.2021.02.010","DOI":"10.1016\/j.jtct.2021.02.010"},{"key":"141964","doi-asserted-by":"crossref","unstructured":"Fernandes JF, Nichele S, Arcuri LJ, Ribeiro L, Zamperlini-Netto G, Loth G, et al. Outcomes after haploidentical stem cell transplantation with post-transplantation cyclophosphamide in patients with primary immunodeficiency diseases. Biol Blood Marrow Transplant. 2020;26:1923-9. https:\/\/doi.org\/10.1016\/j.bbmt.2020.07.003","DOI":"10.1016\/j.bbmt.2020.07.003"},{"key":"141965","doi-asserted-by":"crossref","unstructured":"Jones RJ. Haploidentical transplantation: Repurposing cyclophosphamide. Biol Blood Marrow Transplant. 2012;18:1771-2. https:\/\/doi.org\/10.1016\/j.bbmt.2012.09.005","DOI":"10.1016\/j.bbmt.2012.09.005"},{"key":"141966","doi-asserted-by":"crossref","unstructured":"Faraci M, Bagnasco F, Leoni M, Giardino S, Terranova P, Subissi L, et al. Evaluation of chimerism dynamics after allogeneic hematopoietic stem cell transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant. 2018;24:1088-93. https:\/\/doi.org\/10.1016\/j.bbmt.2017.12.801","DOI":"10.1016\/j.bbmt.2017.12.801"},{"key":"141967","doi-asserted-by":"crossref","unstructured":"Olaya M, Franco A, Chaparro M, Estupi\u00f1\u00e1n M, Aristiz\u00e1bal D, Builes-Restrepo N, et al. Hematopoietic stem cell transplantation in children with inborn errors of immunity: A multicenter experience in Colombia. J Clin Immunol. 2020;40:1116-23. https:\/\/doi.org\/10.1007\/s10875-020-00856-w","DOI":"10.1007\/s10875-020-00856-w"},{"key":"141968","doi-asserted-by":"crossref","unstructured":"Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. 2010;363:2600-10. https:\/\/doi.org\/10.1056\/NEJMoa1007097","DOI":"10.1056\/NEJMoa1007097"},{"key":"141969","doi-asserted-by":"crossref","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190-7. https:\/\/doi.org\/10.1006\/clim.1999.4799","DOI":"10.1006\/clim.1999.4799"},{"key":"141970","doi-asserted-by":"crossref","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011;118:4041-52. https:\/\/doi.org\/10.1182\/blood-2011-03-278127","DOI":"10.1182\/blood-2011-03-278127"},{"key":"141971","doi-asserted-by":"crossref","unstructured":"Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity. J Allergy Clin Immunol Pract. 2019;7:1763-70. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.004","DOI":"10.1016\/j.jaip.2019.02.004"},{"key":"141972","doi-asserted-by":"crossref","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: Working definitions. Biol Blood Marrow Transplant. 2009;15:1628-33. https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.004","DOI":"10.1016\/j.bbmt.2009.07.004"},{"key":"141973","doi-asserted-by":"crossref","unstructured":"Lum SH, Hoenig M, Gennery AR, Slatter MA. Conditioning regimens for hematopoietic cell transplantation in primary immunodeficiency. Curr Allergy Asthma Rep. 2019;19:52. https:\/\/doi.org\/10.1007\/s11882-019-0883-1","DOI":"10.1007\/s11882-019-0883-1"},{"key":"141974","doi-asserted-by":"crossref","unstructured":"Al-Homsi AS, Roy TS, Cole K, Feng Y, Duffner U. Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21:604-11. https:\/\/doi.org\/10.1016\/j.bbmt.2014.08.014","DOI":"10.1016\/j.bbmt.2014.08.014"},{"key":"141975","doi-asserted-by":"crossref","unstructured":"Kanda Y, Hyo R, Yamashita T, Fujimaki K, Oshima K, Onoda M, et al. Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor. Am J Hematol. 200;81:838-44. https:\/\/doi.org\/10.1002\/ajh.20710","DOI":"10.1002\/ajh.20710"},{"key":"141976","doi-asserted-by":"crossref","unstructured":"Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey J, et al. IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97:855-64. https:\/\/doi.org\/10.1046\/j.1365-2141.1997.1112925.x","DOI":"10.1046\/j.1365-2141.1997.1112925.x"},{"key":"141977","doi-asserted-by":"crossref","unstructured":"Carreras E, Dufour C, Mohty M, Kr\u00f6ger N. The EBMT Handbook: Hematopoietic stem cell transplantation and cellular therapies [internet]. 7th edition. Cham (CH): Springer; 2019. https:\/\/doi.org\/10.1007\/978-3-030-02278-5","DOI":"10.1007\/978-3-030-02278-5"},{"key":"141978","doi-asserted-by":"crossref","unstructured":"Rujkijyanont P, Morris C, Kang G, Gan K, Hartford C, Triplett B, et al. Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia. Blood Cancer J. 2013;3:e137. https:\/\/doi.org\/10.1038\/bcj.2013.39","DOI":"10.1038\/bcj.2013.39"},{"key":"141979","doi-asserted-by":"crossref","unstructured":"Umeda K, Adachi S, Tanaka S, Miki M, Okada K, Hashii Y, et al. Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases. Pediatr Blood Cancer. 2016;63:2221-9. https:\/\/doi.org\/10.1002\/pbc.26141","DOI":"10.1002\/pbc.26141"},{"key":"141980","doi-asserted-by":"crossref","unstructured":"Kim HT, Armand P. Clinical endpoints in allogeneic hematopoietic stem cell transplantation studies: The cost of freedom. Biol Blood Marrow Transplant. 2013;19:860-6. https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.003","DOI":"10.1016\/j.bbmt.2013.01.003"},{"key":"141981","doi-asserted-by":"crossref","unstructured":"Comans-Bitter WM, De Groot R, van Den Beemd R, Neijens HJ, Hop WC, Groeneveld K, et al. Immunophenotyping of blood lymphocytes in childhood: Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388-93. https:\/\/doi.org\/10.1016\/s0022-3476(97)70200-2","DOI":"10.1016\/S0022-3476(97)70200-2"},{"key":"141982","doi-asserted-by":"crossref","unstructured":"Hladun R, Badell I, Gonz\u00e1lez M, Mart\u00ednez AM, S\u00e1nchez de Toledo J, Oliv\u00e9 MT, et al. Survival analysis of hematopoietic stem cell transplantation in children with primary immunodeficiency in Spain. An Pediatr (Barc). 2015;82:62-7. https:\/\/doi.org\/10.1016\/j.anpedi.2014.04.014","DOI":"10.1016\/j.anpede.2014.12.001"},{"key":"141983","doi-asserted-by":"crossref","unstructured":"Ariffin H, Ab Rahman S, Jawin V, Foo JC, Amram NF, Mahmood NM, et al. Haematopoietic stem cell transplantation for inborn errors of immunity: 25-year experience from University of Malaya Medical Centre, Malaysia. J Paediatr Child Health. 2020;56:379-83. https:\/\/doi.org\/10.1111\/jpc.14621","DOI":"10.1111\/jpc.14621"},{"key":"141984","doi-asserted-by":"crossref","unstructured":"Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: Entering a new century, do we do better? J Allergy Clin Immunol. 2010;126:602-10.e1-11. https:\/\/doi.org\/10.1016\/j.jaci.2010.06.015","DOI":"10.1016\/j.jaci.2010.06.015"},{"key":"141985","doi-asserted-by":"crossref","unstructured":"Fernandes JF, Nichele S, Daudt LE, Tavares RB, Seber A, Kerbauy FR, et al. Transplantation of hematopoietic stem cells for primary immunodeficiencies in Brazil: Challenges in treating rare diseases in developing countries. J Clin Immunol. 2018;38:917-26. https:\/\/doi.org\/10.1007\/s10875-018-0564-1","DOI":"10.1007\/s10875-018-0564-1"},{"key":"141986","doi-asserted-by":"crossref","unstructured":"Yi ES, Choi YB, Lee NH, Lee JW, Sung KW, Koo HH, et al. Allogeneic hematopoietic cell transplantation in patients with primary immunodeficiencies in Korea: Eleven-year experience in a single center. J Clin Immunol. 2018;38:757-66. https:\/\/doi.org\/10.1007\/s10875-018-0542-7","DOI":"10.1007\/s10875-018-0542-7"},{"key":"141987","doi-asserted-by":"crossref","unstructured":"Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: A PIDTC natural history study. Blood. 2017;130:2718-27. https:\/\/doi.org\/10.1182\/blood-2017-05-781849","DOI":"10.1182\/blood-2017-05-781849"},{"key":"141988","doi-asserted-by":"crossref","unstructured":"Klein OR, Chen AR, Gamper C, Loeb D, Zambidis E, Llosa N, et al. Alternative-donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for nonmalignant disorders. Biol Blood Marrow Transplant. 2016;22:895-901. https:\/\/doi.org\/10.1016\/j.bbmt.2016.02.001","DOI":"10.1016\/j.bbmt.2016.02.001"},{"key":"141989","doi-asserted-by":"crossref","unstructured":"Neven B, Diana JS, Castelle M, Magnani A, Rosain J, Touzot F, et al. Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children. Biol Blood Marrow Transplant. 2019;25:1363-73. https:\/\/doi.org\/10.1016\/j.bbmt.2019.03.009","DOI":"10.1016\/j.bbmt.2019.03.009"},{"key":"141990","doi-asserted-by":"crossref","unstructured":"D\u00edaz de Heredia C, Ortega JJ, D\u00edaz MA, Oliv\u00e9 T, Badell I, Gonz\u00e1lez-Vicent M, et al. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies. Bone Marrow Transplant. 2008;41:627-33. https:\/\/doi.org\/1010.1038\/sj.bmt.170594","DOI":"10.1038\/sj.bmt.1705946"},{"key":"141991","doi-asserted-by":"crossref","unstructured":"Scarselli A, Di Cesare S, Capponi C, Cascioli S, Romiti ML, Di Matteo G, et al. Longitudinal evaluation of immune reconstitution and B-cell function after hematopoietic cell transplantation for primary immunodeficiency. J Clin Immunol. 2015;35:373-83. https:\/\/doi.org\/10.1007\/s10875-015-0154-4","DOI":"10.1007\/s10875-015-0154-4"},{"key":"141992","doi-asserted-by":"crossref","unstructured":"Uppuluri R, Jayaraman D, Sivasankaran M, Patel S, Vellaichamy Swaminathan V, Vaidhyanathan L, et al. Hematopoietic stem cell transplantation for primary immunodeficiency disorders: Experience from a referral center in India. Indian Pediatr. 2018;55:661-4.","DOI":"10.1007\/s13312-018-1354-9"},{"key":"141993","doi-asserted-by":"crossref","unstructured":"Chang YJ, Xu LP, Wang Y, Zhang XH, Chen H, Chen YH, et al. Effects of Low-dose glucocorticoid prophylaxis on chronic graft-versus-host disease and graft-versus-host disease-free, relapse-free survival after haploidentical transplantation: Long-term follow-up of a controlled, randomized open-label trial. Biol Blood Marrow Transplant. 2019;25:529-37. https:\/\/doi.org\/10.1016\/j.bbmt.2018.11.020","DOI":"10.1016\/j.bbmt.2018.11.020"},{"key":"141994","doi-asserted-by":"crossref","unstructured":"Patiroglu T, Akar H, Ozdemir A, Karakukcu M. Hematopoietic stem cell transplant for primary immunodeficiency diseases: A single-center experience. Exp Clin Transplant. 2017;15:337-43. https:\/\/doi.org\/10.6002\/ect.2015.0233","DOI":"10.6002\/ect.2015.0233"},{"key":"141995","doi-asserted-by":"crossref","unstructured":"Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132:1737-49. https:\/\/doi.org\/10.1182\/blood-2018-03-840702","DOI":"10.1182\/blood-2018-03-840702"},{"key":"141996","doi-asserted-by":"crossref","unstructured":"Thakar MS, Logan BR, Puck JM, Dunn EA, Buckley RH, Cowan MJ, et al. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: A 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. Lancet. 2023;402:129-40. https:\/\/doi.org\/10.1016\/S0140-6736(23)00731-6","DOI":"10.1016\/S0140-6736(23)00731-6"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7560\/5636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7560\/5736","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7560\/5636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:11:45Z","timestamp":1773321105000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":45,"journal-issue":{"issue":"Sp. 2","published-online":{"date-parts":[[2024,12,23]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7560","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"2024-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Art\u00edculos originales","name":"content_type","label":"Content Type"}]}}